Trial reportJournal of diabetes science and technology2018
Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control in Patients With Diabetes in Comparison to Blood Glucose Meters Without Color (ACCENTS Study).
Trial report in Journal of diabetes science and technology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02929654 (Assessment of Blood Glucose Monitoring Devices With New Insight Features), which is not on this map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Assessment of Blood Glucose Monitoring Devices With New Insight Features
Who cites it
22 citing papers in PubMed, 29 citations in OpenAlex.
- Telehealth insulin titration in adults with diabetes: a randomized controlled trial comparing bluetooth-enabled versus traditional glucometers.Frontiers in endocrinology · 2025Trial
- Comparative analysis of dapagliflozin and linagliptin in managing type 2 diabetes mellitus and heart failure: A retrospective study.Medicine · 2025Observational
- Improved Glycemic Control Using a Bluetooth®-Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144 000 People With Diabetes.Journal of diabetes science and technology · 2024Article
- User Performance Evaluation and System Accuracy Assessment of Four Blood Glucose Monitoring Systems With Color Coding of Measurement Results.Journal of diabetes science and technology · 2024Article
- Unleashing the Potential of Blood Glucose Monitoring Data With the Ambulatory Glucose Profile Report.Clinical diabetes : a publication of the American Diabetes Association · 2024Article
- Enhancing diabetes therapy adherence: a comprehensive study on glucometer usability for type 2 diabetes patients.Frontiers in clinical diabetes and healthcare · 2024Article
- Sustained Improvements in Readings in-Range Using an Advanced BluetoothDiabetes therapy : research, treatment and education of diabetes and related disorders · 2023Article
- Real-World Evidence of Improved Glycemic Control in People with Diabetes Using a Bluetooth-Connected Blood Glucose Meter with a Mobile Diabetes Management App.Diabetes technology & therapeutics · 2022Article
- Glucometer Usability for 65+ Type 2 Diabetes Patients: Insights on Physical and Cognitive Issues.Sensors (Basel, Switzerland) · 2022Article
- Article
- More Green, Less Red: How Color Standardization May Facilitate Effective Use of CGM Data.Journal of diabetes science and technology · 2022Article
- Healthcare Professional Perceptions of Blood Glucose Meter Features That Support Achievement of Self-Management Goals Recommended by Clinical Practice Guidelines.Journal of diabetes science and technology · 2021Article
- Patients With Diabetes Using a New Glucose Meter With Blood Sugar Mentor and Dynamic Color Range Indicator Features Show Improved Interpretation and Willingness to Act on Blood Glucose Results (ASCEND Study).Journal of diabetes science and technology · 2021Article
- A Payer Digital Health Study Shows Scalable Approach to Cost Savings and Outcomes.Journal of diabetes science and technology · 2021Article
- Potential Cost Savings for the Healthcare System of the Russian Federation Through the Utilization of a Blood Glucose Meter With Color Range Indicator.Journal of diabetes science and technology · 2021Article
- Clinical Characteristics and Glucose Monitoring Satisfaction Associated With Blood Glucose Meter Featuring Color Range Indicator in Patients With Type 2 Diabetes.Journal of diabetes science and technology · 2021Article
- Article
- Budget Impact of Improved Diabetes Management by Utilization of Glucose Meters With a Color-Range Indicator-Comparison of Five European Healthcare Systems.Journal of diabetes science and technology · 2020Article
- Pan-European Economic Analysis to Identify Cost Savings for the Health Care Systems as a Result of Integrating Glucose Monitoring Based Telemedical Approaches Into Diabetes Management.Journal of diabetes science and technology · 2019Article
- Health Care Professionals' Clinical Perspectives and Acceptance of a Blood Glucose Meter and Mobile App Featuring a Dynamic Color Range Indicator and Blood Sugar Mentor: Online Evaluation in Seven Countries.JMIR human factors · 2019Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe ability of patients to improve glycemic control depends partly on their ability to interpret and act on blood glucose results. We investigated whether switching people with diabetes to blood glucose meters (BGMs) featuring a color range indicator (CRI) could improve glycemic control compared to remaining on their current BGM without color.
methods163 adults with type 1 (T1D) or type 2 diabetes (T2D) and a hemoglobin A1c (A1c) of 7.5-11% were randomized to: One Touch Verio™ (Verio), OneTouch Verio Flex™ (Flex), or controls remaining on their current BGM. Diabetes nurses had standard conversations about diabetes management with all subjects at baseline. No changes in medication, insulin dosing, or SMBG frequency were recommended.
resultsAfter 12 weeks, subjects who switched to Verio or Flex meters with CRI (n = 108) had a mean change in A1c 0.36% lower than controls (n = 55) ( P = .017). A1c reductions were greatest in T1D subjects (n = 45), with a decrease of 0.50% ( P = .004). T1D subjects using Verio meters (n = 25) contributed a 0.59% reduction compared to controls ( P < .008), whereas T1D subjects using Flex meters (n = 20) had a clinical meaningful reduction in A1c of 0.40% without reaching statistical significance ( P > .05). Verio and Flex users reported taking more action and easier understanding of diabetes management compared to previous BGMs.
conclusionsThis study demonstrated that switching patients to BGMs featuring a CRI resulted in improvements in glycemic control compared to subjects using currently marketed BGMs that do not use a CRI. Registration: Clinicaltrials.gov NCT02929654 https://clinicaltrials.gov/ct2/show/NCT02929654.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.